말초혈관 디바이스 시장(2024-2034년)

The global Peripheral Vascular Devices market is projected to grow at a CAGR of 8.5% by 2034

The Peripheral Vascular Devices Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

R&D Investments Projected to Drive Industry Growth

Market participants are engaging in R&D investment to manufacture innovative peripheral vascular devices, aiming to enhance their effectiveness and safety while also raising public awareness through the introduction of new technologies and treatments. For instance, in March 2024, Medtronic expanded its Medtronic Engineering and Innovation Center (MEIC) in Hyderabad as part of its commitment to invest over $350 million over five years. This investment is intended to bolster the research and development capabilities of the center and increase its workforce from approximately 950 employees to 1,500. On 1st December 2023, BIOTRONIK unveiled the inauguration of its latest Asia Pacific Manufacturing and Research Hub. Spanning 20,000 m2, the site is designated as the primary center for BIOTRONIK's operations including manufacturing, R&D, and sales & marketing in the Asia Pacific region. This new facility will contribute expertise across various therapy domains, including interventional cardiology, peripheral interventions, cardiac rhythm management, endoscopy, neuromodulation, and urology and pelvic health, thereby strengthening Boston Scientific's presence and capabilities in India.

Product Recall Likely to Challenge Industry Growth

The market growth of peripheral vascular devices has been significantly hampered by product recalls, eroding consumer trust, heightening regulatory scrutiny, imposing financial burdens on manufacturers, and intensifying market competition. In 2023, Cordis US Corp recalled the INFINITI Angiographic Catheter due to shipment without proper sterilization procedures, while Terumo Aortic recalled specific lots of the TREO Abdominal Stent-Graft Systems due to potential issues with graft sizes. Similarly, in April 2024, the FDA issued a Class I Recall for 330,000 Radial Artery Catheterization Kits manufactured by Teleflex and Arrow International. A total of 334,995 affected devices were distributed between December 2021 and January 2024.

These recalls undermine confidence in affected brands or product categories, leading to decreased demand and reluctance to use similar devices among patients and healthcare providers. Regulatory agencies may impose stricter approval requirements, slowing down the entry of new products into the market. Manufacturers incur significant costs related to recalls, investigations, and compensating affected individuals, impacting profitability and research and development investments. Competitors may seize the opportunity to gain market share by offering perceived safer alternatives, heightening competition within the peripheral vascular devices market.

What Questions Should You Ask before Buying a Market Research Report?

How is the peripheral vascular devices market evolving?

What is driving and restraining the peripheral vascular devices market?

How will each peripheral vascular devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each peripheral vascular devices submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading peripheral vascular devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the peripheral vascular devices projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of peripheral vascular devices projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the peripheral vascular devices market?

Where is the peripheral vascular devices market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the peripheral vascular devices market today, and over the next 10 years:

Our 325-page report provides 150 tables and 240 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the peripheral vascular devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising peripheral vascular devices prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Product

Stents: Bare Metal Stents, Drug-eluting Stents

PTA Balloons

Catheters: Angiography Catheters, IVUS/OCT Catheters, Guiding Catheters

Endovascular Aneurysm Repair Stent Grafts: Thoracic Endovascular Aneurysm Stent Grafts, Abdominal Endovascular Aneurysm Stent Grafts

Plaque Modification Devices: Atherectomy Devices, Thrombectomy Devices

Inferior Vena Cava Filters: Permanent Filters, Retrievable Filters

Hemodynamic Flow Alteration Devices: Chronic Total Occlusion Devices, Embolic Protection Devices

Others: Guidewires, Vascular Closure Devices, Balloon Inflation Devices, Introducer Sheaths

End-users

Hospitals

Ambulatory Surgical Centers (ASCs)

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Peripheral Vascular Devices Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

Abbott Laboratories

B. Braun SE

Becton, Dickinson and Company

Biotronik SE & Co KG

Boston Scientific Corporation

Cardinal Health, Inc.

Cook Group, Inc.

Cordis Corp.

Getinge AB

Koninklijke Philips N.V.

Kyoto Medical Planning Co., Ltd.

Medtronic plc

Merit Medical Systems, Inc.

Penumbra Inc.

Terumo Corporation

Overall world revenue for Peripheral Vascular Devices Market, 2024 to 2034 in terms of value the market will surpass US$12.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Peripheral Vascular Devices Market, 2024 to 2034 report help you?

In summary, our 320+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Peripheral Vascular Devices Market, 2024 to 2034, with forecasts for product and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Peripheral Vascular Devices Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Peripheral Vascular Devices Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Peripheral Vascular Devices Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Peripheral Vascular Devices Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
  • 3.2.1 Market Driving Factors
    • 3.2.1.1 Reimbursement for Peripheral Vascular Procedures
    • 3.2.1.2 Rising Prevalence of Diabetic and Obesity Population is Driving the Market
    • 3.2.1.3 Increasing Demand for Minimally Invasive Procedures
    • 3.2.1.4 Rising Geriatric Population
  • 3.2.2 Market Restraining Factors
    • 3.2.2.1 Product Recalls Likely to Restrain Industry Growth
    • 3.2.2.2 Stringent Regulations Limit the Market Growth
    • 3.2.2.3 High Cost of Peripheral Vascular Devices Restraining the Market Growth
    • 3.2.2.4 Availability of Substitute Treatments
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Technological Advancements
    • 3.2.3.2 New Product Launches is Expected to Drive the Market in Near Future
    • 3.2.3.3 Increasing R&D Activities for Novel Device Launch
    • 3.2.3.4 Growing Awareness and Access to Healthcare
• 3.3 COVID-19 Impact Analysis
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Bargaining Power of Suppliers
  • 3.4.2 Bargaining Power of Buyers
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat of Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis

4 Peripheral Vascular Devices Market Analysis by Product

• 4.1 Key Findings
• 4.2 Product Segment: Market Attractiveness Index
• 4.3 Peripheral Vascular Devices Market Size Estimation and Forecast by Product
• 4.4 Stents
  • 4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.4.3 Bare Metal Stents
    • 4.4.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.4.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.4.4 Drug-eluting Stents
    • 4.4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.4.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.5 PTA Balloons
  • 4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.5.2 Market Share by Region, 2024 & 2034 (%)
• 4.6 Catheters
  • 4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6.3 Angiography Catheters
    • 4.6.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.6.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6.4 IVUS/OCT Catheters
    • 4.6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6.5 Guiding Catheters
    • 4.6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.6.5.2 Market Share by Region, 2024 & 2034 (%)
• 4.7 Endovascular Aneurysm Repair Stent Grafts
  • 4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7.3 Thoracic Endovascular Aneurysm Stent Grafts
    • 4.7.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.7.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7.4 Abdominal Endovascular Aneurysm Stent Grafts
    • 4.7.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.7.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.8 Plaque Modification Devices
  • 4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8.3 Atherectomy Devices
    • 4.8.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.8.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8.4 Thrombectomy Devices
    • 4.8.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.8.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.9 Inferior Vena Cava Filters
  • 4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9.3 Permanent Filters
    • 4.9.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.9.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9.4 Retrievable Filters
    • 4.9.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.9.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.10 Hemodynamic Flow Alteration Devices
  • 4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.10.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10.3 Chronic Total Occlusion Devices
    • 4.10.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.10.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10.4 Embolic Protection Devices
    • 4.10.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.10.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.11 Others
  • 4.11.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.11.2 Market Share by Region, 2024 & 2034 (%)
  • 4.11.3 Guidewires
    • 4.11.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.11.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.11.4 Vascular Closure Devices
    • 4.11.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.11.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.11.5 Balloon Inflation Devices
    • 4.11.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.11.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.11.6 Introducer Sheaths
    • 4.11.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.11.6.2 Market Share by Region, 2024 & 2034 (%)

5 Peripheral Vascular Devices Market Analysis by End-users

• 5.1 Key Findings
• 5.2 End-user Segment: Market Attractiveness Index
• 5.3 Peripheral Vascular Devices Market Size Estimation and Forecast by End-users
• 5.4 Hospitals
  • 5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.4.2 Market Share by Region, 2024 & 2034 (%)
• 5.5 Ambulatory Surgical Centers (ASCs)
  • 5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.5.2 Market Share by Region, 2024 & 2034 (%)
• 5.6 Others
  • 5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Peripheral Vascular Devices Market Analysis by Region

• 6.1 Key Findings
• 6.2 Regional Market Size Estimation and Forecast

7 North America Peripheral Vascular Devices Market Analysis

• 7.1 Key Findings
• 7.2 North America Peripheral Vascular Devices Market Attractiveness Index
• 7.3 North America Peripheral Vascular Devices Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 7.4 North America Peripheral Vascular Devices Market Size Estimation and Forecast by Country
• 7.5 North America Peripheral Vascular Devices Market Size Estimation and Forecast by Product
  • 7.5.1 North America Stents Market Size Estimation and Forecast by Type
  • 7.5.2 North America Catheters Market Size Estimation and Forecast by Type
  • 7.5.3 North America Endovascular Aneurysm Repair Stent Grafts Market Size Estimation and Forecast by Type
  • 7.5.4 North America Plaque Modification Devices Market Size Estimation and Forecast by Type
  • 7.5.5 North America Inferior Vena Cava Filters Market Size Estimation and Forecast by Type
  • 7.5.6 North America Hemodynamic Flow Alteration Devices Market Size Estimation and Forecast by Type
  • 7.5.7 North America Others Market Size Estimation and Forecast by Type
• 7.6 North America Peripheral Vascular Devices Market Size Estimation and Forecast by End-users
• 7.7 U.S. Peripheral Vascular Devices Market Analysis
• 7.8 Canada Peripheral Vascular Devices Market Analysis

8 Europe Peripheral Vascular Devices Market Analysis

• 8.1 Key Findings
• 8.2 Europe Peripheral Vascular Devices Market Attractiveness Index
• 8.3 Europe Peripheral Vascular Devices Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 8.4 Europe Peripheral Vascular Devices Market Size Estimation and Forecast by Country
• 8.5 Europe Peripheral Vascular Devices Market Size Estimation and Forecast by Product
  • 8.5.1 Europe Stents Market Size Estimation and Forecast by Type
  • 8.5.2 Europe Catheters Market Size Estimation and Forecast by Type
  • 8.5.3 Europe Endovascular Aneurysm Repair Stent Grafts Market Size Estimation and Forecast by Type
  • 8.5.4 Europe Plaque Modification Devices Market Size Estimation and Forecast by Type
  • 8.5.5 Europe Inferior Vena Cava Filters Market Size Estimation and Forecast by Type
  • 8.5.6 Europe Hemodynamic Flow Alteration Devices Market Size Estimation and Forecast by Type
  • 8.5.7 Europe Others Market Size Estimation and Forecast by Type
• 8.6 Europe Peripheral Vascular Devices Market Size Estimation and Forecast by End-users
• 8.7 Germany Peripheral Vascular Devices Market Analysis
• 8.8 UK Peripheral Vascular Devices Market Analysis
• 8.9 France Peripheral Vascular Devices Market Analysis
• 8.10 Italy Peripheral Vascular Devices Market Analysis
• 8.11 Spain Peripheral Vascular Devices Market Analysis
• 8.12 Russia Peripheral Vascular Devices Market Analysis
• 8.13 Rest of Europe Peripheral Vascular Devices Market Analysis

9 Asia Peripheral Vascular Devices Market Analysis

• 9.1 Key Findings
• 9.2 Asia Peripheral Vascular Devices Market Attractiveness Index
• 9.3 Asia Peripheral Vascular Devices Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 9.4 Asia Peripheral Vascular Devices Market Size Estimation and Forecast by Country
• 9.5 Asia Pacific Peripheral Vascular Devices Market Size Estimation and Forecast by Product
  • 9.5.1 Asia Pacific Stents Market Size Estimation and Forecast by Type
  • 9.5.2 Asia Pacific Catheters Market Size Estimation and Forecast by Type
  • 9.5.3 Asia Pacific Endovascular Aneurysm Repair Stent Grafts Market Size Estimation and Forecast by Type
  • 9.5.4 Asia Pacific Plaque Modification Devices Market Size Estimation and Forecast by Type
  • 9.5.5 Asia Pacific Inferior Vena Cava Filters Market Size Estimation and Forecast by Type
  • 9.5.6 Asia Pacific Hemodynamic Flow Alteration Devices Market Size Estimation and Forecast by Type
  • 9.5.7 Asia Pacific Others Market Size Estimation and Forecast by Type
• 9.6 Asia Pacific Peripheral Vascular Devices Market Size Estimation and Forecast by End-users
• 9.7 Japan Peripheral Vascular Devices Market Analysis
• 9.8 China Peripheral Vascular Devices Market Analysis
• 9.9 India Peripheral Vascular Devices Market Analysis
• 9.10 Australia Peripheral Vascular Devices Market Analysis
• 9.11 South Korea Peripheral Vascular Devices Market Analysis
• 9.12 Rest of Asia Peripheral Vascular Devices Market Analysis

10 Latin America Peripheral Vascular Devices Market Analysis

• 10.1 Key Findings
• 10.2 Latin America Peripheral Vascular Devices Market Attractiveness Index
• 10.3 Latin America Peripheral Vascular Devices Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 10.4 Latin America Peripheral Vascular Devices Market Size Estimation and Forecast by Country
• 10.5 Latin America Peripheral Vascular Devices Market Size Estimation and Forecast by Product
  • 10.5.1 Latin America Stents Market Size Estimation and Forecast by Type
  • 10.5.2 Latin America Catheters Market Size Estimation and Forecast by Type
  • 10.5.3 Latin America Endovascular Aneurysm Repair Stent Grafts Market Size Estimation and Forecast by Type
  • 10.5.4 Latin America Plaque Modification Devices Market Size Estimation and Forecast by Type
  • 10.5.5 Latin America Inferior Vena Cava Filters Market Size Estimation and Forecast by Type
  • 10.5.6 Latin America Hemodynamic Flow Alteration Devices Market Size Estimation and Forecast by Type
  • 10.5.7 Latin America Others Market Size Estimation and Forecast by Type
• 10.6 Latin America Peripheral Vascular Devices Market Size Estimation and Forecast by End-users
• 10.7 Brazil Peripheral Vascular Devices Market Analysis
• 10.8 Mexico Peripheral Vascular Devices Market Analysis
• 10.9 Argentina Peripheral Vascular Devices Market Analysis
• 10.10 Rest of Latin America Peripheral Vascular Devices Market Analysis

11 MEA Peripheral Vascular Devices Market Analysis

• 11.1 Key Findings
• 11.2 MEA Peripheral Vascular Devices Market Attractiveness Index
• 11.3 MEA Peripheral Vascular Devices Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 11.4 MEA Peripheral Vascular Devices Market Size Estimation and Forecast by Country
• 11.5 MEA Peripheral Vascular Devices Market Size Estimation and Forecast by Product
  • 11.5.1 MEA Stents Market Size Estimation and Forecast by Type
  • 11.5.2 MEA Catheters Market Size Estimation and Forecast by Type
  • 11.5.3 MEA Endovascular Aneurysm Repair Stent Grafts Market Size Estimation and Forecast by Type
  • 11.5.4 MEA Plaque Modification Devices Market Size Estimation and Forecast by Type
  • 11.5.5 MEA Inferior Vena Cava Filters Market Size Estimation and Forecast by Type
  • 11.5.6 MEA Hemodynamic Flow Alteration Devices Market Size Estimation and Forecast by Type
  • 11.5.7 MEA Others Market Size Estimation and Forecast by Type
• 11.6 MEA Peripheral Vascular Devices Market Size Estimation and Forecast by End-users
• 11.7 GCC Peripheral Vascular Devices Market Analysis
• 11.8 South Africa Peripheral Vascular Devices Market Analysis
• 11.9 Rest of MEA Peripheral Vascular Devices Market Analysis

12 Company Profiles

• 12.1 Competitive Landscape, 2023
• 12.2 Strategic Outlook
• 12.3 Becton Dickinson and Co. (BD)
  • 12.3.1 Company Snapshot
  • 12.3.2 Company Overview
  • 12.3.3 Financial Analysis
    • 12.3.3.1 Net Revenue, 2018-2023
    • 12.3.3.2 R&D, 2018-2023
    • 12.3.3.3 Regional Market Shares, 2023
  • 12.3.4 Product Benchmarking
  • 12.3.5 Strategic Outlook
• 12.4 Cook Group, Inc.
  • 12.4.1 Company Snapshot
  • 12.4.2 Company Overview
  • 12.4.3 Product Benchmarking
  • 12.4.4 Strategic Outlook
• 12.5 Boston Scientific Corporation
  • 12.5.1 Company Snapshot
  • 12.5.2 Company Overview
  • 12.5.3 Financial Analysis
    • 12.5.3.1 Net Revenue, 2018-2023
    • 12.5.3.2 R&D, 2018-2023
    • 12.5.3.3 Regional Market Shares, 2023
  • 12.5.4 Product Benchmarking
  • 12.5.5 Strategic Outlook
• 12.6 Abbott Laboratories
  • 12.6.1 Company Snapshot
  • 12.6.2 Company Overview
  • 12.6.3 Financial Analysis
    • 12.6.3.1 Net Revenue, 2018-2023
    • 12.6.3.2 R&D, 2018-2023
    • 12.6.3.3 Regional Market Shares, 2023
  • 12.6.4 Product Benchmarking
  • 12.6.5 Strategic Outlook
• 12.7 Medtronic Plc
  • 12.7.1 Company Snapshot
  • 12.7.2 Company Overview
  • 12.7.3 Financial Analysis
    • 12.7.3.1 Net Revenue, 2018-2023
    • 12.7.3.2 R&D, 2018-2023
    • 12.7.3.3 Regional Market Shares, 2023
  • 12.7.4 Product Benchmarking
  • 12.7.5 Strategic Outlook
• 12.8 Getinge AB
  • 12.8.1 Company Snapshot
  • 12.8.2 Company Overview
  • 12.8.3 Financial Analysis
    • 12.8.3.1 Net Revenue, 2018-2023
    • 12.8.3.2 R&D, 2018-2023
    • 12.8.3.3 Regional Market Shares, 2023
  • 12.8.4 Product Benchmarking
  • 12.8.5 Strategic Outlook
• 12.9 Cardinal Health, Inc.
  • 12.9.1 Company Snapshot
  • 12.9.2 Company Overview
  • 12.9.3 Financial Analysis
    • 12.9.3.1 Net Revenue, 2018-2023
    • 12.9.3.2 Regional Market Shares, 2023
  • 12.9.4 Product Benchmarking
• 12.10 Terumo Corporation
  • 12.10.1 Company Snapshot
  • 12.10.2 Company Overview
  • 12.10.3 Financial Analysis
    • 12.10.3.1 Net Revenue, 2018-2023
    • 12.10.3.2 Regional Market Shares, 2023
  • 12.10.4 Product Benchmarking
  • 12.10.5 Strategic Outlook
• 12.11 Biotronik SE & Co. KG
  • 12.11.1 Company Snapshot
  • 12.11.2 Company Overview
  • 12.11.3 Product Benchmarking
  • 12.11.4 Strategic Outlook
• 12.12 Kyoto Medical Planning Co. Ltd.
  • 12.12.1 Company Snapshot
  • 12.12.2 Company Overview
  • 12.12.3 Product Benchmarking
• 12.13 Koninklijke Philips N.V.
  • 12.13.1 Company Snapshot
  • 12.13.2 Company Overview
  • 12.13.3 Financial Analysis
    • 12.13.3.1 Net Revenue, 2018-2023
    • 12.13.3.2 R&D, 2018-2023
    • 12.13.3.3 Regional Market Shares, 2023
  • 12.13.4 Product Benchmarking
  • 12.13.5 Strategic Outlook
• 12.14 B. Braun SE
  • 12.14.1 Company Snapshot
  • 12.14.2 Company Overview
  • 12.14.3 Financial Analysis
    • 12.14.3.1 Net Revenue, 2018-2023
    • 12.14.3.2 R&D, 2018-2023
    • 12.14.3.3 Regional Market Shares, 2023
  • 12.14.4 Product Benchmarking
• 12.15 Penumbra Inc.
  • 12.15.1 Company Snapshot
  • 12.15.2 Company Overview
  • 12.15.3 Financial Analysis
    • 12.15.3.1 Net Revenue, 2018-2023
    • 12.15.3.2 R&D, 2018-2023
    • 12.15.3.3 Regional Market Shares, 2023
  • 12.15.4 Product Benchmarking
  • 12.15.5 Strategic Outlook
• 12.16 Merit Medical Systems, Inc.
  • 12.16.1 Company Snapshot
  • 12.16.2 Company Overview
  • 12.16.3 Financial Analysis
    • 12.16.3.1 Net Revenue, 2018-2023
    • 12.16.3.2 R&D, 2018-2023
    • 12.16.3.3 Regional Market Shares, 2023
  • 12.16.4 Product Benchmarking
• 12.17 Cordis Corporation
  • 12.17.1 Company Snapshot
  • 12.17.2 Company Overview
  • 12.17.3 Product Benchmarking
  • 12.17.4 Strategic Outlook

13 Conclusion and Recommendations

• 13.1 Concluding Remarks from Visiongain
• 13.2 Recommendations for Market Players